Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Muscle depletion and the prediction of chemotherapy toxicity.

Literature DB >> 23754272

Muscle depletion and the prediction of chemotherapy toxicity.

Maurizio Muscaritoli¹, Alessio Molfino, Filippo Rossi Fanelli.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2013 PMID： 23754272 DOI： 10.1007/s11739-013-0966-2

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

× No keyword cloud information.

24 in total

Review 1. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.

Authors: Emanuel Raschi; Fabrizio De Ponti
Journal: Intern Emerg Med Date: 2011-12-13 Impact factor: 3.397

2. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.

Authors: Masuhiro Nishimura; Shinsaku Naito
Journal: Drug Metab Pharmacokinet Date: 2006-10 Impact factor: 3.614

3. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors: Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal: J Clin Oncol Date: 2011-08-01 Impact factor: 44.544

4. Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.

Authors: Richard L Schilsky
Journal: J Clin Oncol Date: 2009-07-06 Impact factor: 44.544

Review 5. Overview of enzymes of drug metabolism.

Authors: U A Meyer
Journal: J Pharmacokinet Biopharm Date: 1996-10

6. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

Authors: E A Calhoun; C H Chang; E E Welshman; D A Fishman; J R Lurain; C L Bennett
Journal: Oncologist Date: 2001

7. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.

Authors: Charles L Bennett; Elizabeth A Calhoun
Journal: Oncologist Date: 2007-04

8. Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule.

Authors: Elena Magnani; Enrico Farnetti; Davide Nicoli; Bruno Casali; Luisa Savoldi; Chiara Focaccetti; Corrado Boni; Adriana Albini; Maria Banzi
Journal: Intern Emerg Med Date: 2013-04-13 Impact factor: 3.397